Evidence map›Paper›PMID 35416594›Full record

ArticleAIDS and behavior2022

Risk of Severe COVID-19 Disease and the Pandemic's Impact on Service Utilization Among a Longitudinal Cohort of Persons with HIV-Washington, DC.

Anne K Monroe, Jiayang Xiao, Alan E Greenberg, Matt E Levy, Marinella Temprosa, Jenna B Resnik, Amanda D Castel, DC Cohort Executive Committee

Open access · bronzeAbstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 4 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anne K MonroeDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA. amonroe@gwu.edu.ORCID http://orcid.org/0000-0003-3201-3845
Jiayang XiaoDepartment of Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
Alan E GreenbergDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA.
Matt E LevyDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA.
Marinella TemprosaDepartment of Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
Jenna B ResnikDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA.
Amanda D CastelDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA.
DC Cohort Executive Committee
Milken Institute · USWestat (United States) · US

Funding

The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DCR24AI152598 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Amanda Derryck Castel, Marinella Temprosa · 2020 to 2026
$37.9M
National Institute of Allergy and Infectious Diseases 1R24AI152598-01NIAID NIH HHS R24 AI152598
6 · The paper itself

Abstract

People with HIV (PWH) have a high burden of medical comorbidities, potentially putting them at increased risk for severe COVID-19. Additionally, during the COVID-19 pandemic, HIV care delivery has been restructured and the impact on HIV outcomes is unknown. The objectives of this study were first, to examine the risk of severe COVID-19 among PWH, using a definition incorporating clinical risk factors, and second, to examine the pandemic's impact on HIV care. We used data from the DC Cohort, a large cohort of people receiving HIV care in Washington, DC. We found that a high proportion of participants across all age groups qualified as increased (58%) or high risk (34%) for severe COVID-19. Between 2019 and 2020, encounters increased (17.7%, increasing to 23.5% of active DC Cohort participants had an encounter) while laboratory utilization decreased (14.4%, decreasing to 11.4% of active DC Cohort participants had an HIV RNA test performed). Implications of our work include the importance of protecting vulnerable people with HIV from acquiring COVID-19 and potentially manifesting severe complications through strategies including vaccination. Additionally, acknowledging that HIV service delivery will likely be changed long-term by the pandemic, adaptation is required to ensure continued progress towards 90-90-90 goals.

Indexed as

COVID-19HIV InfectionsCohort StudiesDistrict of ColumbiaHumansPandemicsComorbiditiesCOVID-19HIVHIV RNAUtilization

Identifiers

PMID35416594
PMCPMC9005919
OpenAlexW4223544068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.